Clinical Research Directory

Inclusion Criteria: * age 3-14 years * diagnosed with typical or atypical autism spectrum disorder (F84.0 or F84.1) and received at least one therapeutic intervention before enrolling * the ability to follow an oral treatment, with TID/BID/QD administration * the availability to perform 3 sets of blood tests at a clinical laboratory within 6 months (initial, at 3- and 6-months) * the availability to perform 3 visits to the Investigator and 3 psychometric evaluations within 6 months Exclusion Criteria: * patients enrolled in another interventional clinical trial currently or which ended less than 1 month prior to enrolling in this study * known allergy to hive products or one of the substances studied * inability to perform the study requirements (3 visits to the Investigator, 3 psychometric assessments, 3 sets of blood tests) * diagnosis of diabetes * history of seizures/epilepsy * administration of anticoagulants, antiplatelets, thrombolytic agents, low molecular weight heparins, anticonvulsants, insulin, monoamine oxidase inhibitors, non-steroidal anti-inflammatory drugs or thiazide diuretics * allergy to celery and other plants of the Fam. Apiaceaea (Umbelliferae) * abnormally elevated baseline (at V1) values of ferritin, homocysteine, HgbA1c, ESR